Heart Blocks Treatment Devices Market Estimated To Reach $4.74 Billion, Growing At 7.2% CAGR By 2030
What Is The Present Market Size Of The Heart Blocks Treatment Devices Market, And At What Annual Growth Rate Is It Expanding?
The heart blocks treatment devices market size has grown strongly in recent years. It will grow from $3.36 billion in 2025 to $3.59 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising prevalence of cardiovascular disorders, increasing aging population, expansion of hospital cardiac care infrastructure, improved access to cardiac diagnostic services, advancements in implantable device reliability.
The heart blocks treatment devices market size is expected to see strong growth in the next few years. It will grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing adoption of remote patient monitoring, rising investments in cardiac digital health solutions, increasing demand for personalized rhythm management, expansion of home-based cardiac care models, continuous innovation in implantable cardiac devices. Major trends in the forecast period include increasing adoption of advanced pacemaker technologies, rising use of implantable cardiac rhythm devices, growing integration of remote cardiac monitoring systems, expansion of minimally invasive cardiac procedures, enhanced focus on long-term rhythm management.
Claim Your Free Report Sample Today:
What Fundamental Drivers Are Expected To Boost The Heart Blocks Treatment Devices Market Throughout The Forecast Period?
The rising prevalence of cardiovascular disease is expected to propel the growth of the heart blocks treatment devices market going forward. Cardiovascular diseases affect the heart and blood vessels and include conditions such as coronary artery disease, heart failure, and stroke. The rapidly increasing incidence of cardiovascular disease is mostly driven by the aging population, changes in lifestyle and diet, and increasing rates of obesity and diabetes, where heart blocks treatment devices can be used to treat cardiovascular disorders by addressing abnormalities or defects in the structures and blocks of the heart. For instance, in March 2024, according to the according to GOV.UK, a UK-based government services and information provider, in the financial year ending 2023, over 1,862,500 people in England, about 3% of the population had been diagnosed with coronary heart disease (CHD) by a GP. Therefore, the rising prevalence of cardiovascular disease is driving the growth of the heart blocks treatment devices market.
What Are The Key Segmentation Components That Define The Structure Of The Heart Blocks Treatment Devices Market?
The heart blocks treatment devices market covered in this report is segmented –
1) By Clinical Classification: First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block
2) By Product: Transcutaneous Pacing (TCP), Pacemaker
3) By End-User: Hospitals & Cardiac Care Centers, Clinics, Home-Care & Remote Monitoring Users
Subsegments:
1) By First-Degree Heart Block: Cardiac Monitoring Devices, Temporary Pacing Devices (Rare / Symptomatic Cases)
2) By Second-Degree Heart Block: Type I (Wenckebach) Management Devices, Type II Management Devices, Pacemakers
3) By Third-Degree Heart Block: Permanent Pacemakers (Primary Treatment), Cardiac Resynchronization Therapy (CRT) Devices, Temporary Pacing Devices (Acute / Emergency Management)
What Trends Are Driving Change Across The Heart Blocks Treatment Devices Market Landscape?
Major companies operating in the heart block treatment device market are focusing on technological advancements such as dual-chamber pacemakers to provide reliable services to customers. Dual-chamber pacemakers which refer to the technology of leadless pacing systems for treating abnormal or slow heart rhythms. For instance, in November 2023, Abbott Laboratories, a US-based medical device and health care company, launched a dual-chamber pacemaker with the first U.S. implants, as more than 80% of people who need a pacemaker require pacing in two chambers of the heart, the right atrium and right ventricle. The company developed the i2i technology to utilize high-frequency pulses, relaying messages through the naturally conductive characteristics of the body’s blood between each leadless pacemaker.
Who Are The Standout Companies Known For Innovation In The Heart Blocks Treatment Devices Market?
Major companies operating in the heart blocks treatment devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Nihon Kohden Corporation, ZOLL Medical Corporation, LivaNova PLC, Osypka Medical GmbH, Shree Pacetronix Ltd., EBR Systems Inc., Medico S.p.A., Cook Medical, B. Braun SE, Oscor Inc., Pacetronix Ltd., Fukuda Denshi Co. Ltd., Teleflex Incorporated, NIPRO Corporation
Get Your In-Depth Heart Blocks Treatment Devices Market Report Now:
Which Geographical Region Is Projected To Lead The Heart Blocks Treatment Devices Market Throughout The Forecast Period?
North America was the largest region in the heart blocks treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart blocks treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment